Zusammenfassung
Peptide, wie die Angiotensine, Kinine, Endotheline und die natriuretischen Peptide, sind die wichtigsten Regulatorsubstanzen im Herz-Kreislauf-System. Da kardiovaskuläre Regulationsvorgänge meist relativ langsame Prozesse sind, die Minuten bis Tage dauern können, sind Peptide geeignete Transmittersubstanzen, während sie für neuronale Prozesse, die in Bruchteilen von Sekunden ablaufen, weniger brauchbar erscheinen. Die in jenem System wirkenden Neurotransmitter, wie Noradrenalin, Dopamin, Serotonin, Glutamat und Glyzin, können in Zellen mit Hilfe von effizienten Enzymkaskaden in großer Menge hergestellt, in Vesikeln gespeichert und durch Stimuli angeregt schnell freigesetzt werden. Aus dem Extrazellularraum werden sie durch Transportproteine oder abbauende Enzyme ebenso schnell wieder entfernt. Somit ist ihre Wirkung auf nachgeschaltete Zellen räumlich und zeitlich begrenzt und dadurch in der Regel auf den synaptischen Spalt zwischen 2 Neuronen beschränkt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alberts GF, Peifley KA, Johns A, Kleha JF, Winkles JA (1994) Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external auto-crine loop. J Biol Chem 269: 10.112–10.118
Aoyagi T, Izumo S (1993) Mapping of the pressure response element of the c-fos gene by direct DNA injection into beating hearts. J Biol Chem 268: 27.176–27.179
Arai H, Nakao K, Takaya K, Hosoda K, Ogawa Y, Nakanishi S, Imura H (1993) The human endothelin-B receptor gene. J Biol Chem 268: 3.463–3.470
Arinami T, Ishikawa M, Inoue A, Yanagisawa M, Masaki T, Yoshida MC, Hamaguchi H (1991) Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (ednl) to 6p23-p24, the endothelin-2 gene (edn2) to 1p34, and the endothelin-3 gene (edn3) to 20g13.2-g13.3. Am J Hum Genet 48: 990–996
Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC (1989) Mesangial cell, glomerular, and renal vascular responses to endothelin in the kidneys. J Clin Invest 83: 339–342
Bakris GL, Re RN (1993) Endothelin modulates angiotensin II induced mitogenesis of human mesangial cells. Am J Physiol 264: F937–F942
Balakrishnan SM, Wang HD, Gopalakrishnan V, Wilson TW, McNeil JR (1996) Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension 28: 806–809
Bascands JL, Marin-Castano ME, Bompart G, Pecher C, Gaucher M, Girolami JP (1996) Postnatal maturation of the kallikrein-kinin system in the rat kidney: from enzyme activity to receptor gene expression. J Am Soc Nephrol 7: 81–89
Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M (1994) Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanozytes and enteric neurons. Cell 79: 1.277–1.285
Benigni A, Orisio S, Gaspari F, Frusca T, Amuso G, Remuzzi G (1992) Evidence against a pathogenetic role for endothelin in pre-eclampsia. Br J Obstet Gynaecol 99: 798–802
Berge KE, Berg K (1994) No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 45: 169–174
Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S (1990) Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 258: C408–C415
Boheler KR, Carrier, L, Bastie D de la, Allen PD, Komajda M, Mercardier JJ, Schwartz K (1991) Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing adult hearts. J Clin Invest 1: 323–330
Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F (1994) Angiotensin II type 1 receptor gene polymorph-isms in human essential hypertension. Hypertension 24: 63–69
Borkowski JA, Hess JF (1995) Targeted disruption of the mouse B2 bradykinin receptor in embryonic stem cells. Can J Physiol Pharmacol 73: 773–779
Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, Luscher TF (1992) Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 70: 1.191–1.197
Bousso-Mittler D, Galron R, Sokolovsky M (1991) Endothelin/sarafotoxin receptor heterogeneity: evidence for different glycosylation in receptors from different tissues. Biochem Biophys Res Commun 178: 921–926
Brunner F, Toit EF du, Opie LH (1992) Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol 24: 1.291–1.305
Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJL (1994) Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330: 1.629–1.633
Cavero PG, Miller WL, Heublein DM, Margulies KB, Burnett JCJ (1990) Endothelin in experimental congestive heart failure in the anesthesized dog. Am J Physiol 259: F312–F317
Cernacek P, Steward D (1989) Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 161: 562–567
Chang H, Wu GJ, Wang SM, Hung CR (1993 a) Plasma endothelin level changes during hemorrhagic shock. J Trauma 35: 825–833
Chang H, Wu GJ, Wang SM, Hung CR (1993b) Plasma endothelin levels and surgically correctable pulmonary hypertension. Ann Thorac Surg 55: 450–458
Chester AH, O’Neil GS, Allen SP, Luu TN, Tadjkarimi S, Yacoub MH (1992) Effect of endothelin on normal and diseased human coronary arteries. Eur J Clin Invest 22: 210–213
Chirgwin JM Schaefer IM, Diaz JA, Lalley PA (1984) Mouse kidney renin gene is on chromosome one. Somat Cell Mol Genet 10: 633–637
Chou S-Y, Dahhan A, Porush JG (1990) Renal action of endothelin: interaction with prostacyclin. Am J Physiol 259: F645–F652
Clauser E, Gaillard I, Wei L, Corvol P (1989) Regulation of angiotensinogen gene. Am J Hypertens 2: 403–410
Clozel M, Watanabe H (1993) BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrage after intracisternal but not intravenous injection. Life Sci 52: 825–834
Clozel M, Gray GA, Breu V, Löffler B, Osterwald R (1992) The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 186: 867–873
DeNucci G, Thomas R, D’Orleans-Juste P et al. (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 797–800
Dohi Y, Hahn AWA, Boulanger CM, Bühler FR, Löscher TF (1991) Endothelin stimulated by angiotensin II augments contractility of SHR resistance arteries. Hypertension 19(2):131–137
Douglas SA, Louden C, Vickery Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD, Ohlstein EH (1994) A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 75: 190–197
Dzau VJ, Burt DW, Pratt RE (1988) Molecular biology of the renin-angiotensin-system. Am J Physiol 351: F563–F573
Dzau VJ, Gibbons GH, Pratt RE (1991) Molecular mechanisms of vascular renin-angiotensin-system in myointimal hyperplasia. Hypertension [Suppl II] 18: 100–105
Eddahibi S, Raffestin B, Braquet P, Chabrier PE, Adnot S (1991) Pulmonary vascular reactivity to endothelin-1 in normal and chronically pulmonary hypertensive rats. J Cardiovasc Pharmacol [Suppl 7] 17: 5358–5361
Edwards RM, Trizna WT, Ohlstein EH (1990) Renal micro-vascular effects of endothelin. Am J Physiol 259: F217–F221
Ehlers MRW, Fox EA, Strydom DJ, Riordan JF (1989) Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci USA 86: 7.741–7.745
Emoto N, Yanagisawa M (1995) Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270: 15.262–15.268
Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O’Rourke DF, Cambien F (1994) Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. QJM 87: 211–214
Fareh J, Touyz RM, Schiffrin EL, Thibault G (1996) Endothelin 1 and angiotensin II receptors in cells from rat hyper-trophied heart. Receptor regulation and intracellular Ca2+ modulation. Circ Res 78: 302–311
Ferrario RG, Foulkes R, Salvati P, Patrono C (1989) Hemodynamic and tubular effects of endothelin and thromboxane in the isolated perfused rat kidney. Eur J Pharmacol 171: 127–181
Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P (1991) Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol 104: 797–804
Firth JD, Ratcliffe PJ (1992) Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest 90: 1.023–1.031
Fujisaki H, Ito H, Hirata Y, Tanaka M, Hata M, Lin M, Ada-chi S, Akimoto H, Marumo F, Hiroe M (1995) Natriuretic peptides inhibit angiotensin II induced proliferation of rat cardiac fibroblasts by blocking endothelin 1 gene expression. J Clin Invest 96: 1.059–1.065
Fulton DJ, Hodgson WC, Sikorski BW, King RG (1991) Attenuated responses to endothelin-1, KC1 and CaC12, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 104: 928–932
Gaillard I, Clauser E, Corvol P (1989) Structure of human angiotensinogen gene. DNA 8: 87–99
Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328: 1.732–1.739
Giuffrida R, Bellomo M, Polizzi G, Malatino LS (1992) Ischemia-induced changes in the immunoreactivity for endothelin and other vasoactive peptides in the brain of the Mongolian gerbil. J Cardiovasc Pharmacol [Suppl 12] 20: S41–S44
Goetz K, Wang BC, Leadley R, Zhu JL, Madwed J, Bie P (1989) Endothelin and safarotoxin produce dissimilar effects on renal blood flow, but both block the antidiuretic effects of vasopressin. Proc Soc Exp Biol Med 191: 425–427
Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J (1996) Effects and interactions of endothelin 1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27:885–892
Goodfriend TL, Elliott ME, Catt KJ (1996) Angiotensin receptors and their antagonists. N Engl J Med 334: 1.649–1.654
Goraya TY, Kessler SP, Kumar RS, Douglas J, Sen GC (1994) Identification of positive and negative transcriptional regulatory elements of the rabbit angiotensin-converting enzyme gene. Nucleic Acids Res 22: 1.194–1.201
Griendling KK, Murphy TJ, Alexander RW (1993) Molecular biology of the renin-angiotensin-system. Circulation 87: 1.816–1.828
Griffin SA, Brown WC, MacPherson F (1991) Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626–632
Grover GJ, Sleph PG, Fox M, Trippodo NC (1992) Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts. J Pharmacol Exp Ther 263: 1.074–1.082
Guo D-F, Furuta H, Mizukoshi M, Inagami T (1994) The genomic organization of human angiotensin II type 1 receptor. Biochem Biophys Res Commun 200: 313–319
Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH (1992) Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 5: 161–165
Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel J-M (1994) Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93: 1.285–1.287
Hattori Y, Kasai K, Nakamura T, Emoto T, Shimoda S (1991) Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism 40: 165–169
Heyman SN, Clark BA, Kaiser N, Epstein FH, Spokes K, Rosen S, Brezis M (1992) In-vivo and in-vitro studies on the effect of amphotericin B on endothelin release. J Antimicrob Chemother 29: 69–77
Hinson JP, Vinson GP, Kapas S, Teja R (1991) The role of endothelin in the control of adrenocortical function: stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin-3 on steroidogenesis in rat and human adrenocortical cells. J Endocrinol 128: 275–280
Hirata Y, Matsuoka H, Kimura K, Fukui K, Hayakawa H, Suzuki E, Sugimoto T, Yanagisawa M, Masaki T (1989a) Renal vasoconstriction by the endothelial cell-derived peptide endothelin in spontaneously hypertensive rats. Circ Res 65: 1.370–1.379
Hirata Y, Takagi Y, Fukuda Y, Marumo F (1989b) Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78: 225–228
Hobart PM, Fogliano M, O’Connor BA, Schaefer IM, Chirgwin JM (1984) Human renin gene: structure and sequence analysis. Proc Natl Acad Sci USA 81: 5.026–5.030
Hocher B, Liefeldt L, Thöne-Reineke C, Orzechowski H-D, Distler A, Bauer C, Paul M (1996) Characterization of the renal phenotype of transgenic rats expressing the human ET-2 gene. Hypertension 28: 196–201
Hoehe MR, Ehrenreich H, Otterud B, Caenazzo L, Plaetke R, Zander H, Leppert M (1993) The human endothelin-1 gene (EDN1) encoding a peptide with potent vasoactive properties maps distal to HLA on chromosome arm 6p in close linkage to D6S89. Cytogenet Cell Genet 62: 131–135
Hosoda K, Nakao K, Tamura N, Arai H, Ogawa Y, Suga S, Nakanishi S, Imura H (1992) Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem 267: 18.797–18.804
Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, Yanagisawa M (1994) Targeted and natural (Piedal-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79: 1.267–1.276
Ide K, Yamakawa K, Nakagomi T, Sasaki T, Saito I, Kurihara H, Yosizumi M, Yazaki Y, Takakura K (1989) The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhage. Neurol Res 11: 101–104
Ihling C, Goebel HR, Lippoldt A, Wessels S, Paul M, Schaefer HE, Zeiher AM (1996) ET-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of ET-1. J Pathol 179: 303–308
Imai T, Miyazaki H, Hirose S, Hori H, Hayashi T, Kageyama R, Ohkubo H, Nakanishi S, Murakami K (1983) Cloning and sequence analysis of cDNA for human renin precursor. Proc Natl Acad Sci USA 80: 7.405–7.409
Ishibashi M, Haizuka H, Tsukamura T, Furue H, Yamaji T (1992) Endothelin-1 and blood pressure (letter). Am J Hypertens 5: 772–774
Ishiye M, Umemura M, Uematsu T, Nakashima M (1995) Angiotensin AT, receptor mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin. Eur J Pharmacol 280: 11–17
Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Murumo F, Hiroe M (1993) Endothelin 1 is an autocrine/paracrine factor in the mechanism of angiotensin II induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92: 398–403
Iyer SN, Lu D, Katovich MJ, Raizada MK (1996) Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc Natl Acad Sci USA 93: 9.960–9.965
Izumo S, Nadal-Ginard B, Mandavi V (1988) Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85: 339–343
Janas J, Sitkiewicz D, Pulawska MF, Warnawin K, Janas RM (1994) Purification of endothelin-1 inactivating peptidase from the rat kidney. J Hypertens 12: 375–382
Jeunemaitre X, Rigat B, Charru A, Houot A-M, Soubrier F, Corvol P (1992a) Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 88: 301–306
Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P (1992b) Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 7–20
Johnston CI (1992) Franz-Volhard-lecture. Benin-angiotensin-system: a dual tissue and hormonal system for cardiovascular control. J Hypertens Suppl 10: S13–26
Julkunen H, Saijonmaa O, Gronhagen Riska C, Teppo AM, Fyhrquist F (1991) Raised plasma concentrations of endothelin-1 in systemic lupus erythematosus [letter]. Ann Rheum Dis 50: 526–527
Kageyama R, Ohkubo H, Nakanishi S (1984) Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence. Biochemistry 23: 3.603–3.609
Kanno K, Hirata Y, Numano F, Emori T, Ohta K, Shichiri M, Marumo F (1990) Endothelin-1 and vasculitis [letter]. JAMA 264: 2.868
Kanyicska B, Freeman ME (1993) Charaterization of endothelin receptors in the anterior pituitary gland. J Physiol (Paris) 265: E601–E608
Karne S, Jayawickreme CK, Lerner MR (1993) Cloning and characterization of a ET-3 specific receptor (ET-C) from Xenopus laevis dermal melanophores. J Biol Chem 268: 19.126–19.133
Kawaguchi H, Sawa H, Yasuda H (1991) Effect of endothelin on angiotensin converting enzyme activity in cultured pulmonary artery endothelial cells. J Hypertens 9: 171–174
Kawamura M, Ohgawara H, Naruse M, Suzuki N, Iwasaki N, Naruse K, Hori S, Demura H, Omori Y (1992) Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes Care 15: 1.396–1.397
Kelleher JP, Shah V, Godley ML, Wakefield AJ, Gordon I, Ransley PG, Snell ME, Risdon RA (1992) Urinary endothelin (ET1) in complete ureteric obstruction in the miniature pig. Urol Res 20: 63–65
Kiff RJ, Gardiner SM, Compton AM, Bennett T (1991) The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 103: 1.321–1.326
Koh E, Morimoto S, Kim S, Nabata T, Miyashita Y, Ogihara T (1990) Endothelin stimulates Na+/H+ exchange in vascular smooth muscle cells. Biochem Mol Biol Int 20: 375–380
Kohno M, Yasunari K, Murakawa K-I, Yokokawa K, Horio T, Fukui T, Takeda T (1990) Plasma immunoreactive endothelin in essential hypertension. Am J Med 88: 614
Kohno M, Murakawa K, Horio T, Yokokawa K, Yasunari K, Fukui T, Takeda T (1991) Plasma immunoreactive endothelin-1 in experimental malignant hypertension. Hypertension 18: 93–100
Koike G, Horiuchi M, Yamada T, Szpirer C, Jacob HJ, Dzau VJ (1994) Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung. Biochem Biophys Res Commun 203: 1.842–1.850
Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang T (1994) Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch mediated cardiomyocyte hypertrophy in vitro. Circulation 89: 2.204–2.211
Komuro I, Yazaki Y (1993) Control of cardiac gene expres- sion by mechanical stress. Annu Rev Physiol 55: 55–75
Komuro I, Katoh Y, Kaida Y, Shibazaki Y, Kurabayashi M, Hoh E, Takaku F, Yazaki Y (1991) Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cariomyocytes. Possible role of protein kinase C activation. J Biol Chem 266: 1.265–1.268
Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I (1990) Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 37: 1.487–1.491
Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T (1989) Plasma endothelin levels in patients with uraemia. Lancet I: 991–992
Kurihara H, Yamaoki K, Nagai R, Yoshizumi M, Takaku F, Satoh H, Inui J, Yazaki Y (1989) Endothelin: a potent vasoconstrictor associated with coronary vasospasm. Life Sci 44: 1.937–1.943
Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N et al. (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703–710
Kurihara Y, Kurihara H, Oda H, Maemura K, Nagai R, Ishikawa T, Yazaki Y (1995) Aortic arch malformations and ventricular septal defect in mice deficient in endothelin1. J Clin Invest 96: 293–300
Lam HC, Takahashi K, Ghatei MA, Warrens AN, Rees AJ, Bloom SR (1991) Immunoreactive endothelin in human plasma, urine, milk, and saliva. J Cardiovasc Pharmacol [Suppl 7] 17: 5390–5393
Lee M-E, Bloch KD, Clifford JA, Quertermous T (1990) Functional analysis of the endothelin-1 gene promoter. J Biol Chem 265: 10.446–10.450
Lee AA, Dillman WH, McCulloch AD, Villareal FJ (1995) Angiotensin II stimulates the autocrine production of transforming growth factor beta 1 in adult cardiac fibroblasts. J Mol Cell Cardiol 27: 2.347–2.357
Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC (1991a) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325: 997–1.001
Lerman A, Hildebrand FL Jr, Aarhus LL, Burnett JC (1991 b) Endothelin has biological actions at pathophysiological concentrations. Circulation 83: 1.808–1.814
Levy RD, Langleben D, Cernacek P, Stewart DJ (1990) Increased plasma-levels of the endothelium-derived vasoconstrictor endothelin in pulmonary hypertension marker or mediator of disease? (abstract). Am Rev Respir Dis 141: 889
Liao Y, Husain A (1995) The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases. Can J Cardiol [Suppl F] 11: 13F–19F
Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA (1995) Contribution of kinins to the cardiovascular actions of angiotensin converting enzyme inhibitors. Pharmacol Rev 47: 25–49
Liu J, Chen R, Casley DJ, Nayler WG (1990) Ischemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes. Am J Physiol 258: H829–H835
Lopez MJ, Wong SK-F, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378: 65–68
Maemura K, Kuruhara H, Kurihara Y, Kuwaki T, Kumada M, Yazaki Y (1996) Gene expression of endothelin isoforms and receptors in endothelin-1 knockout mice. J Cardiovasc Pharmacol [Suppl 3] 26: S17–S21
Malek A, Izumo S (1992) Physiological shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium. Am J Physiol 263: C389–C396
Marceau F (1995) Kinin B1 receptors: a review. Immunopharmacology 30: 1–26
Margulies KB, Hildebrand FL, Lerman A, Perrella MA, Burnett JC (1990) Increased endothelin in experimental heart failure. Circulation 82: 2.226–2.230
Martin-Nizard F, Houssaini HS, Lestavel-Delattre S, Duriez P, Fruchart JC (1991) Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett 293: 127–130
Mastrogiannis DS, O’Brien WF, Krammer J, Benoit R (1991) Potential role of endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 165: 1.711–1.716
Mathisen P, Hall C, Simonsen S (1991) Comparative study of atrial peptides ANF (1–98) and ANF (99–126) as diagnostic marker of atrial distension in patients with cardiac disease. Scand J Clin Lab Invest 53: 41–49
Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M, Morimoto S (1991) Conversion of big endothelin-1 to endothelin1 by two-types of metalloproteinases of cultured porcine vascular smooth muscle cells. Biochem Biophys Res Commun 178: 899–905
McMahon EG, Palomo MA, Moore WM (1991) Phosphoramidone blocks the pressor activity of big-endothelin-1 (1–39) and lowers blood pressure in spontanously hypertensive rats. J Cardiovasc Pharmacol [Suppl 7] 17: 26–28
Miller WL, Redfield MM, Burnett JC (1989) Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 83: 317–320
Momose N, Fukuo K, Morimoto S, Ogihara T (1993) Captopril inhibits endothelin 1 secretion from endothelial cells through bradykinin. Hypertension 21: 921–924
Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K (1992) Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327: 1.774–1.778
Morel DR, Lacroix JS, Hemsen A, Steinig DA, Pittet JF, Lundberg JM (1989) Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur J Pharmacol 167: 427–428
Morris BJ, Iwamoto HS, Reid IA (1979) Localisation of angiotensinogen in rat liver by immunohistochemistry. Endocrinology 105: 790–796
Mullins JJ, Peters J, Ganten D (1990) Fulminant hypertension in transgenic rats harbouring the mouse ren-2 gene. Nature 344: 541–544
Nakagomi T, Ide K, Yamakawa K, Sasaki T, Kurihara H, Saito I, Takakura K (1989) Pharmacological effect of endothelin, an endothelium-derived vasoconstrictive peptide, on canine basilar arteries. Neurol Med Chir (Tokyo) 29: 967–974
Nakaki T, Nakayama M, Yamamoto S, Kato R (1989) Endothelin-mediated stimulation of DNA synthesis in vascular smooth muscle cells. Biochem Biophys Res Commun 158: 880–883
Nakamura T, Kasai K, Sekiguchi Y, Banba N, Takahashi K, Emoto T, Hattori Y, Shimoda S (1991) Elevation of plasma endothelin concentrations during endotoxin shock in dogs. Eur J Pharmacol 205: 277–282
Neubauer S, Zimmermann S, Hirsch A, Pulzer F, Tian R, Bauer W, Bauer B, Ertl G (1991) Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury. J Mol Cell Cardiol 23: 1.3971.409
Neyses L, Nouskas J, Luyken J, Fronhoffs S, Oberdorf S, Pfeifer U, Williams RS, Sukathme VP, Vetter H (1993) Induction of immediately early genes by angiotensin II and endothelin 1 in adult rat cardiomyocytes. J Hypertens 11: 927–934
Ohishi M, Fujii K, Minamino T, Hagaki J, Kamitani A, Rakugi H, Zhao Y, Mikami H, Miki T, Ogihara T (1993) A potent genetic risk factor for restenosis (letter). Nat Genet 5: 324–325
Ohnaka K, Tagayanaki R, Yamauchi T, Okazaki H, Ohashi M, Umeda F, Nawata H (1990) Identification and characterization of ECE activity in cultured bovine endothelial cells. Biochem Biophys Res Commun 168: 1.128–1.136
Opgenroth TJ, Wu-Wong JR, Shiosaki K (1992) Endothelinconverting enzymes. FASEB J 6: 2.653–2.659
Orzechowski HD, Richter CM, Funke-Kaiser H, Kröger B, Schmidt M, Menzel S, Bohnemeier H, Paul M (1997) Evidence for alternative promoters directing isoform specific expression of human endothelin converting enzyme-1 mRNA in cultured endothelial cells. J Mol Med 75(7):512–521
Otsuka A, Mikami H, Katahira K, Tsunetoshi T, Minamitami K, Ogihara T (1989) Changes in plasma renin activity and aldosterone concentration in response to endothelin injection in dogs. Acta Endocrinol (Copenh) 121: 361–364
Otsuka A, Kikami H, Katahira K, Tsunetoshi T, Kohara K, Minamitami K, Marigushi A, Ogihara T (1990) Evidence for direct arrhythmogenic action of ET. Clin Exp Pharmacol Physiol 17: 351–160
Paul M, Zintz M, Böcker W, Dyer M (1995) Analysis and functional characterization of the rat endothelin-1 promoter. Hypertension 25: 683–687
Perico N, Dadan J, Remuzzi G (1990) Endothelin mediates the renal vasoconstriction induced by cyclosporine. J Am Soc Nephrol 1: 76–83
Pollock DM, Opgenorth TJ (1993) Evidence for endothelininduced renal vasoconstriction independent of ETA receptor activation. Am J Physiol 264: R222–R226
Pribnow D, Muldoon LL, Fajardo M, Theodor L, Chen LYS, Magun BE (1992) Endothelin induces transcriptional fos/ jun family genes: a prominent role for calcium ion. Mol Endocrinol 6: 1.003–1.012
Puffenberger E, Hosoda K, Washington S, Nakao K, DeWit D, Yanagisawa M, Chakravarti A (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung’s disease. Cell 79: 1.257–1.266
Roubert P, Gillard V, Plas P, Chabrier PE, Braquet P (1990) Downregulation of ET binding sites in rat vascular smooth muscle cells. J Hypertens 3: 310–312
Rubanyi GM, Polokoff MA (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46: 325–415
Sadoshima J, Xu Y, Slayter HS, Izumo S (1993) Autocrine release of angiotensin II mediates stretch induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977–984
Saito Y, Nakao K, Shirakami G, Jougasaki M, Yamada T, Itoh H, Mukoyama M, Arai H, Hosoda K, Suga S et al. (1989) Detection and characterization of endothelin-1-like immunoreactivity in rat plasma. Biochem Biophys Res Commun 163: 1.512–1.516
Sakai S, Yorikane R, Miyauchi T, Sakurai T, Kasuya Y, Yamaguchi I, Sugishita Y, Goto K (1995) Altered production of endothelin 1 in the hypertrophied rat heart. J Cardiovasc Pharmacol 26: S452–S455
Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732–735
Salvati P, Chierchia S, Dho L, Ferrario RG, Parenti P, Vice-domini G, Patrono C (1991) Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow. J Cardiovasc Pharmacol 17: 1.007–1.014
Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6: 29–32
Schiffrin EL, Thibault G (1991) Plasma endothelin in human essential hypertension. Am J Hypertens 4: 303–308
Schott E, Tostes RCA, San H, Paul M, Webb RC, Nabel EG (1997) In vivo gene transfer of a recombinant prepro-ETi gene stimulates vascular contractility. Am J Physiol 272(5Pt2):H2385–H2393
Schunkert H, Ingelfinger JR, Dzau VJ (1991) Evolving concepts of the intrarenal renin-angiotensin-system in health and disease: contributions of molecular biology. Renal Physiol Biochem 14: 146–154
Schunkert H, Sadoshima J, Cornelius T, Kagaya Y, Weinberg O, Izumo S, Riegger G, Lorell BH (1995) Angiotensin II induced growth responses in isolated adult rat hearts. Evidence for load independend induction of cardiac protein synthesis by angiotensin II. Circ Res 76: 489–497
Shigeno T, Mima T (1990) A new vasoconstrictor peptide, endothelin: profiles as vasoconstrictor and neuropeptide. Cerebrovasc Brain Metab Rev 2: 227–239
Shirakami G, Nakao K, Saito Y, Magaribuchi T, Jougasaki M, Mukoyama M, Arai H, Hosoda K, Suga S, Ogawa Y et al. (1991) Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci 48: 969–976
Simonson MS, Rooney A (1994) Characterization of endothelin receptors in mesangial cells: evidence for two functional distinct endothelial binding sites. Mol Pharmacol 46: 41–50
Simonson MS, Jones JM, Dunn MJ (1992a) Differential regulation of fos and jun gene expression and AP-1 cis-element activity by endothelin isopeptides. Possible implications for mitogenic signaling by endothelin. J Biol Chem 267: 8.643–8.649
Simonson MS, Wang Y, Dunn MJ (1992b) Cellular signaling by endothelin peptides: pathways to the nucleus. J Am Soc Nephrol 2: S116–S125
Singer DRJ, Missouris CG, Jeffery S (1996) Angiotensin-converting enzyme gene polymorphism: what to do about all the confusion? Circulation 94: 236–239
Sokolovsky M, Gairon R, Kloog Y, Bdolah A, Indig FE, Blumberg S, Flemiger G (1990) Endothelins are more sensitive than sarfaotoxins to neutral endopeptidase: possible physiologic significance. Proc Natl Acad Sci USA 87: 4.702–4.706
Stelzner TJ, O’Brien RF, Yanagisawa M, Sakurai T, Sato K, Webb S, Zamora M, McMurtry IF, Fisher JH (1992) Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am J Physiol 262: L614–L620
Stewart D, Cernacek P, Costello KB, Rouleau JL (1992) Elevated endothelin-1 in heart failure and loss of normal response to postural change Circulation 85: 510–517
Studer R, Reinecke H, Muller B, Holtz J, Just H, Drexler H (1994) Increased angiotensin I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 94: 301–310
Stula M, Gschwend S, Orzechowski HD, Paul M, Dietz R (1996) Constant mechanical stretch induces the endothelin system and immediately early genes in endothelial cells (abstract). Hypertension 28: 687
Stula M, Pinto YM, Gschwend S, Gilst W van, Teisman AC, Dietz R, Paul M (1998) Interaction of the renin angiotensin-system and the endothelin system in cardiac hypertrophy. J Cardiovasc Pharmacol (in press)
Suzuki N, Miyauchi T, Tomobe Y, Matsumoto H, Goto K, Masaki T, Fujino M (1991) Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOC artery. Circ Res 69: 1.361–1.368
Szpirer C, Riviere M, Szpirer J, Levan G, Guo DF, Iwai N, Inagami T (1993) Chromosomal assignment of human and rat hypertension candidate genes: type 1 angiotensin II receptor genes and the SA gene. J Hypertens 11: 919–925
Tahara A, Kohno M, Yanagi S, Itagane H, Toda I, Akioka K, Teragaki M, Yasuda M, Takeuchi K, Takeda T (1991) Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty. Metabolism 40: 1.235–1.237
Takagi Y, Fukase M, Takata S, Kawakami M, Masui M, Ueda M, Fujita T (1991) Role of endogenous endothelin in the development of hypertension in rats. Am J Hypertens 4: 389–391
Takahashi K, Ghatei MA, Lam HC, O’Halloran DJ, Bloom SR (1990) Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33: 306–310
Takahashi N, Calderone A, Izzo Jr NJ, Maki TM, Marsh JD, Colucci WS (1994) Hypertrophic stimuli induce transforming growth factor beta 1 expression in rat ventricular myocytes. J Clin Invest 94: 1.470–1.476
Takayanagi R, Ohnaka K, Sakai Y, Nakao R, Yanase T, Haji M, Inagami T, Furuta H, Gou D-F, Nakamuta M, Nawata H (1992) Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. Biochem Biophys Res Commun 183: 910–916
Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K (1994) Angiotensinogen-deficient mice with hypotension. J Biol Chem 269: 31.334–31.337
Taylor RN, Varma M, Teng NN, Roberts JM (1990) Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71: 1.675–1.677
Tomobe Y, Miyauchi T, Saito A, Yanagisawa M, Kimura S, Goto K, Masaki T (1988) Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats. Eur J Pharmacol 152: 373–374
Tomoda H (1993) Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J 125: 667–672
Toyo-oka T, Aizawa N, Suzuki N, Hirata Y, Miyaugchi T, Shin WS, Yanagisawa M, Masaui T, Sugimoto T (1991) Inreased plasma levels of endothelin-1 and coronary spasm induced in patients with vasospastic angina pectoris. Circulation 83: 476–483
Vigne P, Ladoux A, Frelin C (1991) Endothelins activate Na+/H+ exchange in brain capillary endothelial cells via a high affinity endothelin-3 receptor that is not coupled to phospholipase C. J Biol Chem 266: 5.925–5.928
Voerman HJ, Stehouwer CD, Kamp GJ van, Strack van Schijndel RJ, Groeneveld AB, Thijs LG (1992) Plasma endothelin levels are increased during septic shock. Crit Care Med 20: 1.097–1.101
Wang DL, Wung BS, Peng YC, Wang JJ (1995) Mechanical strain increases endothelin-1 gene expression via protein kinase c pathway in human endothelial cells. J Cell Physiol 163: 400–406
Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A (1991) Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 69: 370–377
Watschinger B, Vychytil A, Schuller M, Hartter E, Traindl O, Pohanka E, Ulrich W, Kovarik J (1991) The pathophysiologic role of endothelin in acute vascular rejection after renal transplantation. Transplantation 52: 743–746
Weber H, Webb ML, Serafino R, Taylor DS, Moreland S, Norman J, Molloy CJ (1994) Endothelin 1 and angiotensin II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signalling mechanisms. Mol Endocrinol 8: 148–158
Weissberg PL, Witchell C, Davenport AP, Hesketh TR, Metcalfe JC (1990) The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 85: 257–262
Widimsky J Jr, Horky K, Dvorakova J (1991) Plasma endothelin-1,2 levels in mild and severe hypertension. J Hypertens Suppl 9: S194–S195
Wilkins FC, Kassab S, Kato T, Mizelle HL, Opgenorth TJ, Granger JP (1995) Chronic endothelin induced pressor and renal actions in conscious dogs do not require altered Ang II formation. Am J Physiol 268: R395–R402
Willette RN, Sauermelch C, Ezekiel M, Feuerstein G, Ohl-stein EH (1990) Effect of endothelin on cortical micro-vascular perfusion in rats. Stroke 21: 451–458
Winquist RJ, Bunting PB, Garsky VM, Lumma PK, Schofield TL (1989) Prominent depressor response to endothelin in spontaneously hypertensive rats. Eur J Pharmacol 163: 199–203
Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M (1994) ECE-1: a membrane bound metallo-protease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473–485
Yamada T, Horiuchi M, Dzau VJ (1996) Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93: 156–160
Yamane K, Kashiwagi H, Suzuki N, Miyauchi T, Yanagisawa M, Goto K, Masaki T (1991) Elevated plasma levels of endothelin-1 in systemic sclerosis (letter). Arthritis Rheum 34: 243–244
Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H (1990) Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett 267: 16–18
Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Yazaki Y (1996) Endothelin 1 is involved in mechanical stress induced cardiomyocyte hypertrophy. J Biol Chem 271: 3.221–3.228
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Katsutoshi G, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415
Yanagisawa M, Masaki T (1989) Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 10: 374–378
Yandle TG, Richards AM, Nicholls MG, Cuneo R, Espiner EA, Livesey JH (1986) Metabolic clearance rate and plasma half life of alpha human atrial natriuretic peptide in man. Life Sci 38: 1.827–1.833
Yang Z, Richard V, Segesser L von, Bauer E, Stulz P, Turina M, Löscher TF (1990) Threshold concentrations of enothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. Hypertension 82: 188–195
Yasujima M, Abe K, Kanazawa M, Yoshida K, Kohzuki M, Takeuchi K, Tsunoda K, Kudo K, Hiwatari M, Sato T (1991) Antihypertensive effect of captopril and enalapril in endothelin infused rats. Tohoku J Exp Med 163: 219–227
Yokokawa K, Tahara H, Kohno M, Murakawa K, Yasunari K, Nakagawa K, Hamada T, Otani S, Yanagisawa M, Takeda T (1991) Endothelin-secreting tumor. J Cardiovasc Pharmacol [Suppl 7] 17: S398–3401
Zamora MR, O’Brien RF, Rutherford RB, Weil JV (1990) Serum endothelin-1 and cold provocation in primary Raynaud’s phenomenon. Lancet 336: 1.144–1.147
Zeiher AM, Goebel H, Schachinger V, Ihling C (1995) Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 91: 941–947
Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M (1992) Increased plasma endothelin-1 in acute ischemic stroke. Stroke 23: 1.014–1.016
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stula, M., Schott, E., Paul, M. (1998). Bedeutung peptiderger Systeme bei der Genese kardiovaskulärer Erkrankungen. In: Ganten, D., Ruckpaul, K. (eds) Herz-Kreislauf-Erkrankungen. Handbuch der Molekularen Medizin, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80360-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-80360-4_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80361-1
Online ISBN: 978-3-642-80360-4
eBook Packages: Springer Book Archive